Table 3 Counterfactual predictions by treatment arm and observed outcome.
From: Towards causal inference-based antidepressant selection with brain and blood biomarkers
Placebo Arm | |||
---|---|---|---|
Stage 2 treatment | Observed Outcome | Mean prediction of remission if patient treated with Sertraline | Mean prediction of remission if patient remained on Placebo |
Placebo | Non-remitters | 0.42* | 0.47 |
Placebo | Remitters | 0.52* | 0.93 |
Sertraline | Non-remitters | 0.40 | 0.83* |
Sertraline | Remitters | 0.60 | 0.90* |
Sertraline Arm | |||
---|---|---|---|
Stage 2 treatment | Observed Outcome | Mean prediction of remission if patient remained on Sertraline | Mean prediction of remission if patient treated with Bupropion |
Sertraline | Non-remitters | 0.55 | 0.35* |
Sertraline | Remitters | 0.72 | 0.29* |
Bupropion | Non-remitters | 0.64* | 0.25 |
Bupropion | Remitters | 0.57* | 0.39 |